Disruption of a putative SH3 domain and the proline-rich motifs in the 53-kDa substrate of the insulin receptor kinase does not alter its subcellular localization or ability to serve as a substrate.
The recently identified 53-kDa substrate of the insulin receptor family was further characterized in several retroviral-generated stable cell lines overexpressing the wild type and various mutant forms of the protein. To facilitate the study of its subcellular localization in NIH3T3 cells overexpressing insulin receptor, a myc epitope-tag was added to the carboxy terminus of the 53-kDa protein. Like the endogenous protein in Chinese hamster ovary cells, the expressed myc-tagged 53-kDa protein was found partially in the particulate fraction and was tyrosine phosphorylated in insulin-stimulated cells. Immunofluorescence studies showed for the first time that a fraction of the 53-kDa protein was localized to the plasma membrane. Confocal microscopy of cells double-labeled with antibodies to the insulin receptor and the myc epitope showed the two proteins co-localize at the plasma membrane at the level of light microscopy. Further analyses of the protein sequence of the 53-kDa substrate revealed the presence of a putative SH3 domain and two proline-rich regions, putative binding sites for SH3 and WW domains. Disruption of these three motifs by the introduction of previously characterized point mutations did not affect the membrane localization of the 53-kDa protein, its ability to serve as substrate of the insulin receptor, or its colocalization with the insulin receptor, suggesting these domains are not important in the subcellular targeting of the protein and instead may function in the interaction with subsequent signaling proteins.
Yeh
T C
TC
Department of Molecular Pharmacology, Stanford University School of Medicine, California 94305, USA.
Li
W
W
Keller
G A
GA
Roth
R A
RA
D016475:3T3 Cells; D000818:Animals; D001665:Binding Sites / Q000502:physiology; D002460:Cell Line; D005455:Fluorescent Antibody Technique; D015870:Gene Expression / Q000235:genetics / Q000502:physiology; D051379:Mice; D016297:Mutagenesis, Site-Directed; D017354:Point Mutation; D011392:Proline / Q000235:genetics / Q000378:metabolism; D011972:Receptor, Insulin / Q000502:physiology*; D013347:Subcellular Fractions / Q000737:chemistry; D013379:Substrate Specificity / Q000502:physiology; D016159:Tumor Suppressor Protein p53 / Q000032:analysis* / Q000235:genetics / Q000502:physiology*; D018909:src Homology Domains / Q000235:genetics / Q000502:physiology*
D016159:Tumor Suppressor Protein p53; D011392:Proline; D011972:Receptor, Insulin